Shared on 03 Nov 25
Fair value Increased 18%Analysts have raised their price target for Strata Critical Medical to $9.25, up from $7.83. They cited stronger strategic deployment of cash resources with the acquisition of Keystone Perfusion Services and improved expectations for future performance.
Shared on 23 Sep 25
Fair value Increased 34%Critical Organ Transport And Joby Aviation Will Expand Healthcare Reach
Strata Critical Medical’s consensus price target has risen from $5.83 to $7.83, as analysts express increased confidence in management’s ability to deploy capital efficiently and drive shareholder value following the accretive acquisition of Keystone Perfusion Services. Analyst Commentary Bullish analysts highlight the successful deployment of Strata's large $235M pro forma cash position through the acquisition of Keystone Perfusion Services for $124M.
Shared on 06 Aug 25
Fair value Decreased 19%Critical Organ Transport And Joby Aviation Will Expand Healthcare Reach
The consensus analyst price target for Blade Air Mobility has increased, primarily driven by higher revenue growth forecasts and a rising future P/E, bringing the fair value estimate up from $7.20 to $7.75. What's in the News Joby Aviation is exploring an acquisition of Blade Air Mobility to access a ready customer base for electric air taxis; no final decision has been made.
Shared on 24 Apr 25
Fair value Increased 0.70%eVTOL And Urban Air Mobility Will Open New Routes
Shared on 17 Apr 25
eVTOL And Urban Air Mobility Will Open New Routes
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
eVTOL And Urban Air Mobility Will Open New Routes
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 0.56%eVTOL And Urban Air Mobility Will Open New Routes
AnalystConsensusTarget made no meaningful changes to valuation assumptions.